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Phosphatidylinositol 4,5-biphosphate kinases (PIP5Ks) are critical regulators of T cell 
activation being the main enzymes involved in the synthesis of phosphatidylinositol 
4,5-biphosphate (PIP2). PIP2 is indeed a pivotal regulator of the actin cytoskeleton, thus 
controlling T cell polarization and migration, stable adhesion to antigen-presenting cells, 
spatial organization of the immunological synapse, and co-stimulation. Moreover, PIP2 
also serves as a precursor for the second messengers inositol triphosphate, diacylglyc-
erol, and phosphatidylinositol 3,4,5-triphosphate, which are essential for the activation 
of signaling pathways regulating cytokine production, cell cycle progression, survival, 
metabolism, and differentiation. Here, we discuss the impact of PIP5Ks on several T 
lymphocyte functions with a specific focus on the role of CD28 co-stimulation in PIP5K 
compartimentalization and activation.
Keywords: PiP5K, actin cytoskeleton, T cell signaling, metabolism, CD28 co-stimulation
inTRODUCTiOn
Phosphatidylinositol 4,5-biphosphate kinases (PIP5Ks) are a family of isoenzymes that mediate 
the phosphorylation of phosphatidylinositol 4-phosphate on the D5 position of the inositol ring, 
thus inducing the production of phosphatidylinositol 4,5-biphosphate (PIP2) (1) (Figure 1). PIP2 
is a phospholipid located in the inner leaflet of the plasma membrane that plays a pivotal role in 
several signaling processes, ranging from the regulation of cytoskeleton dynamics controlling cell 
migration and cell–cell adhesion to second messenger generation (2, 3). In T lymphocytes, PIP2 
regulates the cytoskeleton reorganization events necessary for lymphocyte polarization and migra-
tion, the formation of stable T: antigen-presenting cell (APC) conjugates and the further clustering 
of TCR, co-stimulatory and signaling molecules at the immunological synapse (IS) (4). PIP2 also 
serves as a precursor for second messengers inositol triphosphate (IP3), diacylglycerol (DAG), and 
phosphatidylinositol 3,4,5-triphosphate (PIP3) (Figure 1B), which are essential for the activation of 
the signaling pathways regulating efficient cytokine production, cell cycle progression, survival, and 
T cell metabolism (5).
Three PIP5K isoforms (α, β, and γ) and further splice variants have been identified (6–8). Primary 
T cells express all three PIP5K isoforms (9), with differential subcellular localizations, thus providing 
both temporarily and spatially regulated distinct pools of PIP2 (10–14).
This review illustrates the most relevant functional roles of the different PIP5K isoforms in T cell 
activation and highlights the molecules and mechanisms involved in their recruitment and activation.
FiGURe 1 | Structure and functions of PiP5Ks. (A) Schematic 
representation of human PIP5K (hPIP5K) isoforms with the conserved kinase 
core domain. (B) PIP5K isoforms phosphorylate phosphatidylinositol 
4-phosphate (PI4P) in the D5 position of the inositol ring to generate 
phosphatidylinositol 4,5-bisphosphate (PIP2). PIP2 may be hydrolyzed by 
phospholipase C (PLC) to generate inositol-1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG) second messengers or phosphorylated in the D3 
position by class 1 phosphatidylinositol 3-kinase (PI3K) to generate 
phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP2 may also directly 
interact with effector proteins.
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PiP5K STRUCTURe AnD ACTiviTY 
ReGULATiOn
In both humans and mice, all PIP5K isoforms display further 
variation in their sequence by alternative splicing. Three PIP5Kα, 
four β, and one γ splice variants have been identified in humans 
(Figure 1A), and eight PIP5Kα, two β, and three γ splice variants 
are present in mice. All PIP5K isoforms and splice variants contain a 
highly conserved kinase domain of 330–380 amino acids with a sub-
domain, known as the activation loop, which regulates their activity 
and subcellular localizations (4). The variables N- and C-termini of 
PIP5K isoforms are also involved in the regulation of lipid kinase 
activity and in targeting PIP5Ks to specific cellular compartments 
(3). The last 28 aminoacids of human PIP5Kγ control the interac-
tion of the kinase with talin during the adhesion to the extracellular 
matrix (15, 16). The C-terminal residues (440–562) of PIP5Kα regu-
late its localization at nuclear speckles (17). The 83 C-terminal amino 
acids of PIP5Kβ are essential for its polarization at the uropod (18), 
whereas the N-terminus controls PIP5Kβ targeting to the plasma 
membrane and its dimerization with other PIP5K isoforms (19).
Most of the proteins that regulate PIP5K activity belong to the 
Rho family of small GTPases, which are critical regulators of actin 
remodeling, vesicular trafficking, and signal transduction (20). In 
several cell types, Rho, Rac1, and Cdc42 have been reported to 
interact with all PIP5K isoforms and to activate them in a GTP-
independent manner (10, 21).
In addition to Rho, the ADP-ribosylation factor (ARF) GTPases 
have also been identified as upstream regulators of PIP5K activ-
ity at the plasma membrane. ARF GTPases regulate intracellular 
vesicle trafficking. In particular, ARF6 organizes cortical actin 
and regulates the traffic between the plasma membrane and the 
endosomal compartments (22). Several in vitro and in vivo stud-
ies have evidenced a direct role of the membrane-bound ARF6 in 
activating all PIP5K isoforms (23–25).
All PIP5K isoforms are stimulated by phosphatidic acid 
(PA), which is generated by phospholipase D (PLD), through 
the hydrolysis of phosphatidylcholine (26, 27). For instance, 
both PIP5Kα and PIP5Kγ have been described to interact and 
colocalize with PLD2 at the membrane to stimulate cell adhesion 
(28, 29).
The activity of PIP5Ks is also regulated by phosphorylation 
on Ser/Thr and Tyr residues. For example, phosphorylation of 
PIP5Kβ at Ser214 (30) and PIP5Kγ at Ser264 (31) in the kinase 
homology domain have been described as inhibiting PIP5K 
activity. Phosphorylation of PIP5Kγ on Ser645 inhibits PIP5Kγ 
interaction with talin (32). Conversely, phosphorylation of tyr644 
by Src kinase activates PIP5Kγ (33), whereas tyrosine phospho-
rylation of PIP5Kβ exerts inhibitory effects (34).
PiP5Ks AnD THe ReGULATiOn OF T CeLL 
POLARiZATiOn, ADHeSiOn, AnD iS 
FORMATiOn
Optimal T cell activation requires the recognition of  peptide–
MHC by TCR together with co-stimulatory signals, generally 
provided by counterreceptors expressed on the surface of 
APCs. CD28 may be considered the most important co-stim-
ulatory molecule. By binding B7.1/CD80 and/or B7.2/CD86, 
expressed on the surface of activated APCs (i.e., macrophages, 
dendritic cells, and B lymphocytes), CD28 delivers signals 
essential for optimal T cell expansion, differentiation, and 
effector functions (35).
Activation of T cells by APCs bearing the appropriate 
peptide–MHC complexes initiates with the polarization of 
membrane receptors and signaling molecules in specific cell 
locations and is governed by rapid cytoskeletal reorganization 
events. The dynamic and organization of actin cytoskeleton is 
tightly regulated by PIP2, which may directly interact with several 
actin-binding proteins (36), such as talin, vinculin, and filamin 
(37, 38), thus controlling the selective localization of scaffolding 
molecules linking the actin cytoskeleton to the plasma membrane 
(39). Already before interacting with APCs, T cells exhibit a 
polarized morphology with a leading edge enriched in actin fila-
ments and an uropod enriched in ezrin, moesin, and vimentin 
filaments (40). The analysis of the distribution of different PIP5K 
isoforms in mouse T cells revealed that PIP5Kβ and PIP5Kγ90 
are predominantly found at the distal pole and in the uropod, 
thus suggesting a role in adhesion during extravasation from the 
vasculature (9).
Upon encountering with an APC-bearing specific peptide–
MHC complexes, T cells undergo rapid changes in cytoskeletal 
rearrangements, such as uropod retraction and a strong increase 
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of actin polymerization at the T:APC contact zone. The accumula-
tion of actin and actin-binding proteins in the T:APC contact zone 
is important for the formation of a stable T:APC conjugate that is 
necessary for the further clustering of TCR, co-stimulatory, and 
signaling molecules at the IS (41, 42). Stable conjugate formation 
requires the interaction between the T cell β2 integrin leukocyte 
functional antigen-1 (LFA-1) with its ligand intercellular adhe-
sion molecule-1 (ICAM-1) on APCs. LFA-1 activity is regulated 
by the transition from a low-intermediate to a high-activation 
state that results in an increase of its affinity for ICAM-1 (43). 
PIP5Kγ has been described to selectively regulate the affinity of 
LFA-1 for ICAM-1 by acting downstream of Rho and Rac1 and 
favoring T  cell arrest and stable adhesion (44). More detailed 
analysis of the role of PIP5Kγ isoforms in knockout mice revealed 
that CD4+ T cells from PIP5Kγ90-deficient mice have increased 
LFA-1 adhesion to ICAM-1 and T:APC conjugate formation, 
as well as increased proliferation and cytokine production in 
response to TCR and CD28 co-engagement (45). Consistent 
with these data, the two PIP5Kγ isoforms show different cellular 
localizations during T:APC interaction, with PIP5Kγ87 rapidly, 
but transiently recruited to the site of T:APC contacts and 
PIP5Kγ90 in the uropod (9).
Once LFA-1 has mediated a stable contact of T cells with 
APCs, sustained cytoskeleton rearrangement events occur for 
the relocalization of receptors, lipid rafts, and signaling com-
plexes at the IS. In particular, the engagement of the TCR and 
co-stimulatory molecules at the IS promotes the organization of a 
signaling compartment by inducing cytoskeletal rearrangements 
and lipid raft accumulation (46–48). All these events are neces-
sary for enhancing TCR-controlled signaling pathways (48–50).
As in other cell types, actin polymerization at the IS is regulated 
by the Rho family small G proteins, in particular Cdc42 (51), and 
its guanine nucleotide exchange factor Vav1 (52–55). Following 
tyrosine phosphorylation and activation, Vav1 promotes the 
exchange of GDP to GTP and the activation of Cdc42. In the GTP-
bound form, Cdc42 interacts with the neuronal Wiskott–Aldrich 
syndrome protein (N-WASP) that, in turn, binds the actin-related 
protein (ARP) 2/3 complex to promote actin polymerization (56). 
The ARP2/3 complex cooperates with filamins in establishing 
cortical actin architecture (57). Filamin-A is predominantly 
expressed in the immune system and participates in T cell activa-
tion (58, 59). CD28 is the crucial determinant of T lymphocyte 
activation, as it promotes the cytoskeletal rearrangement events 
required for the organization of a signaling compartment at the IS 
(46, 59). CD28 binds and promotes the tyrosine phosphorylation 
and activation of Vav1 (60–62). CD28 also recruits filamin-A to 
the membrane, where filamin-A cooperates with Vav1 to inte-
grate signaling pathways resulting in actin polymerization and 
lipid raft mobilization (59, 63).
Lipid rafts are cholesterol-/sphingolipid-enriched membrane 
domains, which provide a dynamic lipid environment where 
critical signaling proteins accumulate (64). Approximately, half 
of the PIP2 pool associates with membrane rafts (65, 66), which 
also exhibit locally regulated PIP2 turnover (67). Furthermore, 
WASP stabilization at the membrane depends on the interac-
tion of its PH domain with PIP2, thus the activity of PIP5Ks is 
essential for TCR- and CD28-mediated actin reorganization. 
For instance, recent data from our group evidenced that human 
PIP5Kβ is recruited to the IS in a CD28-dependent manner and 
that PIP5Kβ is pivotal for both the recruitment of filamin-A and 
the accumulation of lipid rafts to the IS. We also demonstrated 
that PIP5Kβ cooperates with PIP5Kα and Vav1 in promoting 
actin polymerization and CD28 signaling functions in human 
T lymphocytes (Figure 2A) (60, 68, 69).
Interestingly, enough, recent data by Choudhuri et  al. 
evidenced a novel function of TCR accumulation at the IS, 
which involves the TCR sorting and release in extracellular 
microvesicles that in turn deliver transcellular signals by engag-
ing cognate peptide–MHC on APC (70). Similar mechanisms 
of exchange of molecules through exosomes and microvesicles 
during IS have been previously described (71). Since ARF6 and 
PIP5Ks are crucial regulators of the traffic of vesicles (23–25), it 
would be interesting to assess the role of PIP5Ks in regulating 
cell–cell communication through the microvesicles exchange 
at the IS.
PiP5Ks AnD THe ReGULATiOn OF THe 
CALCineURin/nF-AT AnD nF-κB 
SiGnALinG PATHwAYS
One key role of PIP2 is to regulate TCR signaling by serving 
as a substrate for the generation of second messengers. TCR 
stimulation induces the tyrosine phosphorylation of the immu-
noreceptor tyrosine-based activation motifs (ITAMs) of CD3 
and ζ chains, which in turn bind the Syk family tyrosine kinase 
Zap-70. Following activation by p56lck and/or p59fyn, Zap-70 
phosphorylates the linker for activation of T cells (LAT) that 
binds and recruits to the membrane the phospholipase C γ1 
(PLC-γ1) (72). PLCγ1 hydrolyzes PIP2 into DAG and IP3. While 
DAG remains in the cellular membrane and activates the RAS/
protein kinase C (PKC) θ pathway (73, 74), soluble IP3 induces 
a strong increase of intracellular Ca2+ and the activation of the 
Ca2+/calmodulin-dependent calcineurin. Calcineurin in turn 
dephosphorylates NF-AT transcription factors (NF-ATc1, c2, 
and c3 in lymphocytes), thus leading to their translocation into 
the nucleus, where they bind specific DNA response elements in 
the promoter of genes critical for T cell functions, such as the 
IL-2 gene (75). TCR stimulation alone is not sufficient to activate 
this pivotal signaling pathway and requires the co-engagement of 
CD28 co-stimulatory molecule (49, 76).
Initial studies by Zaru et al. demonstrated that PIP2 turnover 
induced by TCR engagement and CD28 co-stimulation was 
required for sustained Ca2+ increase (77). Furthermore, Singleton 
et  al. showed that PIP2 accumulates at the IS during antigen 
recognition, where it is rapidly consumed by PLCγ1 (78). In 
response to several receptors, PIP5Kα isoform is recruited to the 
plasma membrane, where it provides the substrate PIP2 for PLCγ, 
thus inducing IP3 formation and Ca2+ mobilization (79–81). We 
extended these data to T lymphocytes, by demonstrating that 
CD28 co-stimulation regulates PIP2 turnover by recruiting and 
activating PIP5Kα at the IS, thus sustaining TCR-stimulated 
Ca2+ influx and NF-AT nuclear translocation and activation 
(Figure 2B) (68, 69).
FiGURe 2 | CD28-induced regulation of PiP5Kα/β at the iS. (A) Following engagement by B7, human CD28 binds Vav1 that in turn favors the recruitment of 
PIP5Kα and PIP5Kβ. PIP5Kα generates PIP2 that favors the recruitment of the WASP/Cdc42/ARP2/3 complex, which, in turn, promotes actin polymerization. 
PIP5Kβ mediates the recruitment of filamin-A (FLN-A) and lipid rafts to the T:APC contact zone. (B) Upon TCR recognition of peptide–MHC complexes presented on 
the surface of APCs, Lck and Fyn phosphorylate CD3 and ζ chains, which bind ZAP-70. ZAP-70 phosphorylates LAT that in turn binds PLC-γ1. CD28 mediates the 
recruitment of Vav-associated PIP5Kα that generates PIP2. PLC-γ1 hydrolyzes PIP2 in IP3 and DAG. IP3 induces the activation of Ca2+/calcineurin (CN) and NF-AT. 
CD28 also binds class 1A PI3K that phosphorylates PIP2 and generates PIP3 that favors the recruitment and activation of Akt. Akt cooperates with DAG to activate 
PKCθ/CARMA1/Bcl10/MALT1 complex and NF-κB.
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Phosphatidylinositol 4,5-biphosphate 2 also serves as a 
substrate of PI3K. Although TCR stimulation has been shown 
to induce PI3K activation (82), CD28 is known to give a major 
contribution in activating PI3K (83). Indeed, CD28 short cyto-
plasmic tail contains an N-terminal YMNM motif that, following 
phosphorylation, binds the p85 subunit of class 1A PI3K (84–86). 
Class 1A PI3K phosphorylates PIP2 and generates PIP3 (87), 
which binds the PH domains of several molecules involved in T 
cell activation, such as phosphoinositide-dependent protein kinase 
1 (PDK1), AKT, and Vav1 (88). PDK1 contributes to the canonical 
NF-κB pathway by associating with caspase recruitment domain 
membrane-associated guanylate kinase protein 1 (CARMA1) and 
leading to the membrane recruitment and activation of PKCθ (89, 
90). The ternary complex CARMA1/Bcl10/mucosa-associated 
lymphoid tissue lymphoma translocation protein 1 (MALT1) links 
TCR to the inhibitor of NF-κB kinase (IKK) α/γ/β complex, thus 
leading to the phosphorylation-dependent degradation of inhibi-
tor of NF-κB (IκB) and activation of RelA/p50 or c-Rel/p50 dimers 
(74, 91, 92). CD28 co-segregates with PKCθ to a spatially unique 
subregion within the IS (93), where it favors the activation of 
CARMA1/Bcl10/MALT1 complex and IKKs (74). Furthermore, 
PDK1 recruitment to the membrane also leads to the phospho-
rylation and activation of Akt (94, 95), which in turn cooperates 
with PKCθ in stimulating the NF-κB cascade (Figure 2B) (96).
In addition to cooperate with TCR in inducing NF-κB acti-
vation, CD28 is also able to autonomously activate IKKα and a 
non-canonical NF-κB2-like cascade leading to the nuclear trans-
location and activation of RelA/p52 dimers (55, 97). This CD28 
unique signaling to NF-κB converges to the selective regulation of 
the expression of several genes, including anti- and pro-apoptotic 
gene of Bcl-2 family (98), the LTR of HIV-1 virus (99), and pro-
inflammatory cytokine/chemokines (100, 101). The relevance of 
PIP5Kα in CD28-dependent NF-κB activation has been recently 
demonstrated by the impairment of CD28 autonomous signaling 
regulating NF-κB transcriptional activation and IL-8 gene tran-
scription induced by a lipid-kinase-dead mutant of PIP5Kα in 
CD4+ T cells (60). The intracytoplasmic C-terminal PYAP motif 
of CD28 is essential for both NF-κB activation and PIP5Kα and 
β recruitment. Watanabe et al. reported that the substitution of 
the two proline residues in the C-terminal PYAP motif of murine 
CD28 strongly reduces NF-κB transcriptional activity (102). 
Yokosuka et al. further showed that this motif is involved in the 
recruitment of PKCθ to the IS and its colocalization with CD28 
(93). More recently, we evidenced that this motif is also important 
for the activation of CD28-induced non-canonical NF-κB2-like 
cascade by binding and recruiting to the membrane IKKα and 
the IKKα activator NF-κB-inducing kinase (NIK) (63). Our find-
ings that C-terminal PYAP is fundamental for both PIP5Kα and 
β recruitment strengthens the relevance of PIP5Ks in regulating 
NF-κB-dependent gene expressions in T lymphocytes.
Finally, PIP5Kα and PIP5Kγ have also been found into the 
nucleus in specific structures called interchromatin granule 
clusters or nuclear speckles, where they may regulate pre-mRNA 
processing and mRNA export (103).
POTenTiAL ROLe OF PiP5Ks in THe 
ReGULATiOn OF GLUCOSe MeTABOLiSM 
in T CeLLS
Another important contribution of class 1A PI3K in T cell activa-
tion and differentiation is the regulation of glucose metabolism 
(104). Indeed, upon antigen stimulation, T cells rapidly switch 
from a catabolic oxidative metabolic state to an anabolic glycolitic 
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metabolic program. By phosphorylating PIP2, class 1A PI3K gen-
erates PIP3 lipids that recruit and activate the PDK1/Akt pathway. 
The PI3K/PDK1/Akt pathway triggers the translocation of the 
high-affinity glucose transporter 1 (Glut1) from the cytosol to 
the cell membrane, thus increasing glucose uptake and glycoslysis 
(105). PI3K/PDK1/Akt also activates the mammalian target of 
rapamycic complex 1 (mTORC1) that stimulates the activity 
of several transcription factors, which regulate the expression 
of genes involved in glycolysis. Moreover, mTORC1-induced 
upregulation of the glycolytic pathway also favors the differen-
tiation of specific inflammatory Th cell subsets in the periphery 
(106), in particular, the Th1 and Th17 cell subsets (107), which 
play a pathogenetic role in several autoimmune diseases (108).
Due to its relevant role in activating class 1A PI3K and sus-
taining PIP3 levels, CD28 participates in T cell metabolism by 
enhancing TCR-mediated glucose uptake, aerobic glycolysis, and 
anabolic pathways (109). Moreover, since PIP2 is an essential 
limiting factor ensuring the activation of PI3K following CD28 
engagement, PIP5Ks may be pivotal in regulating glucose 
metabolism in T cells. Understanding the role of PIP5Ks in 
the fine tuning of glucose metabolism in T cells may open new 
therapeutic approaches for treatment of inflammatory diseases. 
Interestingly, recent data from PIP5Kα knockout mice revealed 
faster glucose clearance and resistance to the development of 
obesity on high fat diet (110).
COnCLUDinG ReMARKS
The accumulation and consumption of PIP2 in a strictly 
defined spatiotemporal manner is essential for many cellular 
processes and, indeed, T lymphocyte triggering is finely tuned 
by PIP5Ks activity. Emerging studies linking alterations in the 
metabolism of PIP2 to immune-based diseases suggest that 
PIP5Ks may represent new therapeutic targets to modulate 
immunity and inflammation. Interestingly, a crucial role of 
PIP5Ks in regulating HIV infection has been recently demon-
strated. The attachment of HIV-1 to T lymphocytes through 
CD4/CXCR4 complexes promotes PIP5Kα-dependent PIP2 
production, which in turn induces the reorganization of 
actin cytoskeleton, lipid raft mobilization, and clustering of 
viral receptors, thus finally leading to membrane fusion and 
viral core internalization (111). These results, together with 
the recent identification of one selective inhibitor of PIP5Kα 
that efficiently inhibits advanced prostate cancer progression 
(112), indicate that the investigation of PIP5K functions may 
open up new avenues to novel interesting therapeutic targets 
for several disorders.
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